PBL Learning Objectives Flashcards

1
Q

What is the first step in the mechanism of action of insulin?

A
  1. Insulin binds to insulin receptors (members of the growth factor receptor family)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is special about insulin receptors?

A

They are members of the growth factor receptor family.
-Unlike G-protein associated receptors, these span the membrane just once and acquiring signaling ability through activation of tyrosine kinase activity (intrinsic to individual receptor molecules)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the second step in the mechanism o faction of insulin?

A

Through complex signaling pathway consisting of kinases, phosphatases, and other signaling molecules there are 2 pathways insulin activates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What two pathways does insulin activate?

A
  1. Metabolic

2. Mitogenic signaling pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the function of the metabolic pathway?

A
  1. Activation of phosphatidylinositol-3-kinase leads to the activation of serine/threonine kinase Akt
  2. Akt activation drives the movement of glucose transporter (GLUT) 4-containg vesicles to the cell membrane, increases glycogen and lipid synthesis, and stimulates protein synthesis through the activation of mTOR.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the function of the mitogenic signaling pathway?

A

Activation of RAS initiates a cascade of activating phosphorylations via the MAP kinase pathway, leading to cell growth and proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are 7 overall insulin functions?

A
  1. Inc. transport of glucose into skeletal muscle and adipose tissue
  2. Inc. glycogen synthesis and storage
  3. Inc. triglyceride synthesis
  4. Inc. Na retention in kidneys
  5. Inc. protein synthesis
  6. Inc. cellular uptake of K+ and amino acids
  7. Dec. glucagon release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a primary gain from a patient inducing DKA?

A

Treatment of the medical condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a secondary gain from a patient inducing DKA?

A

Getting attention from boyfriend, people at hospital, family, etc. [External motivator, exaggerating or causing symptoms]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is another way to phrase primary gain?

A

Positive reasons to use treatments (take insulin/go to hospital –> not sick/acidotic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is another way to phrase secondary gain?

A

Reasons patient would want to NOT take treatment (no insulin –> attention from boyfriend and others)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Primary gain vs. Secondary online:

A
  1. Interpersonal, social or financial advantages from the conversion of emotional stress directly into illness (e.g. hysterical blindness or paralysis) –> alleviation of anxiety that results from conversion of emotional conflict to organic illness (defense mechanism)
  2. Interpersonal or social advantages gained indirectly from illness (e.g. assistance, attention, sympathy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the inheritance pattern of Type 1 diabetes?

A

It’s unknown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Does Type 1 diabetes have a hereditary component?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What mutations are associated with an increased risk of developing type 1 diabetes?

A

Mutations in HLA-DR3 and HLA-DR4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the function of HLA?

A

HLA provides instructions for the immune system. The HLA complex helps the immune system distinguish the body’s own protein from proteins made by foreign invaders such as viruses and bacteria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What do monozygotic twin studies indicate about Type 1 diabetes?

A

Cohort studies

-Onset of Type 1 diabetes by age 60 years is reported in 65% of monozygotic twins of persons with type 1 diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are non-HLA single nucleotide polymorphisms associated with?

A

Increased risk of developing persistent autoantibodies in children at risk for type 1 diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

In a prospective cohort study where all patients had high-risk HLA genotype for development of type 1 diabetes but lacked a 1st deg. relative with type 1 diabetes, how many participants with polymorphisms developed type 1 DM?

A

24% of participants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the prevalence of Type 1 diabetes?

A

Prevalence of newly diagnosed type 1 diabetes per 1,000 persons:
1.93 overall (out of 1,000)

21
Q

What is the prevalence of newly diagnosed type 1 diabetes per 1,000 people by race?

A
  1. 55 in whites
  2. 62 in blacks
  3. 29 in hispanics
  4. 35 in American indians
22
Q

What are three risk factors for Type 1 diabetes?

A
  1. High birth weight
  2. Childhood obesity
  3. Increasing maternal age at birth
23
Q

What are preventative care and disease-related risk management strategies are appropriate for patients with diabetes?

A

Disease related risk management:

  1. Cigarette smoking –> cessation
  2. Blood pressure raise HDL (no set goal)
  3. Prothrombotic state –> low does aspirin therapy (patients with CHD and other risk factors)
  4. Glucose –> A1C dec. BMI
  5. Exercise prescription based on patient’s status
  6. Nutrition
24
Q

What are the main signs of DKA?

A
  • Kussmaul respirations (rapid/deep breathing)
  • N/V
  • abdominal pain
  • psychosis/delirium
  • dehydration
  • fruity breath (exhaled acetone)
25
Q

What chief concerns are associated with DKA?

A

Polyuria, polydipsia, polyphagia, fatigue, dyspnea, abdominal pain, N/V, HA, confusion, lethargy

26
Q

What are precipitating factors for DKA?

A
  • New onset DM type 1
  • Fever/signs of infection
  • Reduced insulin intake/inadequate management
  • Atherosclerotic disease
  • Change in eating patterns/eating disorder
  • Pregnancy
  • Increased alcohol intake/illicit drug use
  • Changes in medications
  • Other stressors (trauma, pancreatitis, psychological stress)
27
Q

What is Rapid acting insulin?

A

Ultra rapid

28
Q

What is Short acting insulin?

A

Regular

29
Q

What is Intermediate acting insulin?

A

NPH

30
Q

What is Long acting insulin?

A

Insulin glargine

31
Q

What is the onset of action for rapid acting/ultra rapid insulin (lispro insulin)?

A

0.25 hr (15 min)

32
Q

What is the onset of action for short acting (regular) insulin?

A

0.5 hr (30 min)

33
Q

What is the onset of action for intermediate acting (NPH) insulin?

A

2-4 hours

34
Q

What is the onset of action for long acting (glargine) insulin?

A

1-2 hours

35
Q

What is the peak of action for rapid acting/ultra rapid insulin (lispro insulin)?

A

0.5-1.5 hours

36
Q

What is the peak of action for short acting (regular) insulin?

A

2-3 hours

37
Q

What is the peak of action for intermediate acting (NPH) insulin?

A

4-12 hours

38
Q

What is the peak of action for long acting (glargine) insulin?

A

No peak/relatively flat

39
Q

What is the duration of action for rapid acting/ultra rapid insulin (lispro insulin)?

A

3-4 hours

40
Q

What is the duration of action for short acting (regular) insulin?

A

4-8 hours

41
Q

What is the duration of action for intermediate acting (NPH) insulin?

A

10-20 hours

42
Q

What is the duration of action for long acting (glargine) insulin?

A

18-24 hours

43
Q

What are the three ultra rapid/rapid acting insulins?

A

Insulin lispro
Insulin aspart
Insulin glulisine

44
Q

What is short acting insulin?

A

Regular insulin

45
Q

What is intermediate acting insulin?

A

NPH (neutral protamine hagedorn)

46
Q

What is Long-acting insulin?

A

Insulin glargine & Insulin detemir

47
Q

How does the respiratory system compensate for metabolic acid-base disorders?

A
  • Your body wants to get rid of CO2

- In order to do this, you breathe more (Kussmaul breathing)

48
Q

What is Kussmaul breathing?

A

Air hunger, rapid, deep, labored breathing

49
Q

What is Le Chateliers Principle in relation to Kussmaul breathing?

A

If you breathe off CO2, it shifts the bicarb equation to the left –> this gets rid of H+, decreasing acidity caused by ketoacids

H2O + CO2 H2CO3 H+ + HCO3-